Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Salvarx Group Plc LSE:SALV London Ordinary Share IM00BZ4SS228 ORD 2.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 4.50 - 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.0 -0.5 1.0 4.5 2

Salvarx Share Discussion Threads

Showing 351 to 370 of 525 messages
Chat Pages: 21  20  19  18  17  16  15  14  13  12  11  10  Older
DateSubjectAuthorDiscuss
21/10/2018
17:20
Shame, but a bird in the hand.... Fig.
fig1
21/10/2018
17:18
Similar here Dex. I have a few more @34p. I saw a corporate vid on a J Mellon tweet. Looked interesting to me. I liked the business model. Won't make me a mill but hope for the best. Good luck to you. Fig.
fig1
21/10/2018
16:39
My problem is going to be that I won't want to be holding Portage shares (not even sure i can [Charles Stanley]) so will be looking to sell before the swap...
dexdringle
21/10/2018
16:34
This is way undervalued even pre stunning results. Price agreed is worth $1.60 in portage shares with a healthy percentage of the deal shares remaining in the shell. That wecretwkn our shares in. No brainer chaps.
jonesyboy 27
21/10/2018
15:55
Plenty of screen printe on twitter search #SALV. We will have a very interesting week, expecting portage SH document release by Canadian stock Exchange early this week. Vote then deal very quickly. Don’t forget we get 18 portage shares (value US 8.9 cents each) for every Salv share. Plus get to keep shell shares which are worth ~20p each.
jonesyboy 27
21/10/2018
15:44
fig1. I have a small holding. Just 6,000 shares. A speculative punt at around 34p a share a while ago. Tip from Moneyweek I think but i can't be sure. Could do with a significant winner as am taking a major bath on some other holdings just now.... Jonesboy. Source ? Your estimate of effect it may have on the share price ?
dexdringle
21/10/2018
14:32
The news was stunning. We have proven immuno-response. This is key. Necrosis (death) of the tumour. 90% of the drug remains in the tumour (think about that and the damage current methods do to surrounding tissue). Decrease in cancer related symptoms. All good. This will be taken massive by a major or a partner. In short Tumours die and proven engagement of the immune system. An amazing weekend for any lucky shareholders of SALV. Well done all for holding.
jonesyboy 27
21/10/2018
14:18
Why are you interested Dex? Do you currently have a holding in SalvaRx or FFWD?
fig1
21/10/2018
11:25
I came on here today expecting a load of posts re some news yesterday, as expected in previous posts on here, that Intensity had made a world changing breakthrough and that Salvarx's 9% would be worth a fortune. Instead just tumbleweed.... Presumably no such news / progress after all ?
dexdringle
19/10/2018
15:09
Well I don't want to be short this over the weekend
the stigologist
19/10/2018
00:29
Hmm just one trading day left before the BIG presentation
the stigologist
18/10/2018
12:32
…..the Portage update on 9th October merely confirmed that Canadian Stock Exchange is still 'checking the paperwork': https://www.bloomberg.com/press-releases/2018-10-09/portage-provides-update-on-proposed-acquisition-of-salvarx Good god. How long do these things take ?
dexdringle
17/10/2018
11:10
Fast Forward and Intensity really building up October 20th presentation on Twitter Could/should be interesting weeks ahead
the stigologist
02/10/2018
07:09
Stig - are you old enough to remember Chesney Hawkes ?
dexdringle
01/10/2018
23:54
Portage has a history of creating value for its shareholders - one of its portfolio companies, Biohaven Pharmaceutical Holding Company Ltd ("Biohaven") (NYSE:BHVN), was the second largest biotech IPO on NASDAQ in 2017. Portage subsequently announced a distribution in specie of its stock in Biohaven to its shareholders. Their initial US$7 million investment was worth in excess of US$100 million at the time of the IPO in 2017, and has almost doubled since then. Biohaven is now worth approximately US$1.3 billion. Portage has provided seed capital to four other biotech companies and will seek to evaluate new opportunities. I am excited at the potential of working with the Portage team to progress our combined portfolio.
the stigologist
30/9/2018
18:34
This could just be one of the most profitable trades Jim Mellon has been involved in.
fig1
25/9/2018
05:28
Their website contact form doesn’t work so have had to ask broker to try to get it.
bscuit
15/9/2018
14:17
Bscuit, Did the company respond to your enquiry on that matter?
sweet karolina
13/9/2018
19:44
Much more important is taxation position of the distributed shares if not held in a ISA or similar.
bscuit
13/9/2018
16:20
What happens to 'free float' shares vis a vis Portage shares. Where do they end up? Can mm's profit from holding on to them?
fig1
Chat Pages: 21  20  19  18  17  16  15  14  13  12  11  10  Older
ADVFN Advertorial
Your Recent History
LSE
SALV
Salvarx
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201203 10:34:47